HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shoji Fukushima Selected Research

Carcinogens

3/2013The enhancing effect of ethanol on the mutagenic activation of N-nitrosomethylbenzylamine by cytochrome P450 2A in the rat oesophagus.
3/2010Chemopreventive effects of 13alpha,14alpha-epoxy-3beta-methoxyserratan-21beta-ol (PJJ-34), a serratane-type triterpenoid, in a rat multi-organ carcinogenesis bioassay.
6/2006[Development of invasive urinary bladder carcinomas].
3/2003Enhancement of lung carcinogenesis by nonylphenol and genistein in a F344 rat multiorgan carcinogenesis model.
2/2003Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
1/2003Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work.
1/2003Appropriate models and an understanding of carcinogenic mechanisms--requirements for hazard risk assessment.
10/2002Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine.
10/2002Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens.
7/2002Etiology-specific gene expression profiles in rat mammary carcinomas.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shoji Fukushima Research Topics

Disease

57Neoplasms (Cancer)
11/2015 - 01/2002
18Carcinoma (Carcinomatosis)
10/2015 - 07/2002
13Hyperplasia
10/2015 - 01/2002
12Body Weight (Weight, Body)
01/2015 - 05/2002
8Liver Cell Adenoma (Hepatocellular Adenoma)
10/2015 - 11/2004
7Hepatocellular Carcinoma (Hepatoma)
01/2011 - 11/2004
5Adenocarcinoma
03/2012 - 01/2002
5Fibrosis (Cirrhosis)
01/2010 - 01/2005
5Cystitis
11/2009 - 04/2003
5Aberrant Crypt Foci
01/2005 - 09/2002
4Papilloma (Papillomatosis)
12/2013 - 08/2002
4Urinary Bladder Neoplasms (Bladder Cancer)
11/2010 - 01/2003
4Colonic Neoplasms (Colon Cancer)
03/2009 - 01/2003
4Adenoma (Adenomas)
04/2008 - 01/2002
3Inflammation
10/2014 - 11/2009
3Chromosome Aberrations (Chromosome Abnormalities)
01/2010 - 03/2008
3Infection
08/2008 - 05/2004
2Atrophy
11/2010 - 04/2006
2Polyploidy
01/2010 - 04/2008
2Cholestasis
12/2009 - 09/2009
2Kidney Neoplasms (Kidney Cancer)
12/2009 - 12/2004
2Transitional Cell Carcinoma
01/2009 - 12/2003
2Necrosis
08/2008 - 05/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2008 - 12/2004
2Fibroadenoma
04/2008 - 12/2004
2Gastritis
03/2008 - 09/2004
2Stomach Neoplasms (Stomach Cancer)
03/2008 - 09/2004
2Liver Neoplasms (Liver Cancer)
06/2006 - 07/2002
2Liver Diseases (Liver Disease)
04/2006 - 05/2005
2Liver Cirrhosis (Hepatic Cirrhosis)
05/2005 - 01/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2005 - 11/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2004 - 08/2003
1Adenomatous Polyps
03/2012

Drug/Important Bio-Agent (IBA)

13Glutathione Transferase (Glutathione S-Transferase)IBA
11/2011 - 08/2003
11CarcinogensIBA
03/2013 - 05/2002
8Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2015 - 11/2004
7ArsenicIBA
01/2007 - 01/2002
6ethyl tert-butyl ether (ETBE)IBA
10/2015 - 11/2011
6Messenger RNA (mRNA)IBA
12/2009 - 08/2003
68-hydroxy-2'-deoxyguanosineIBA
08/2008 - 09/2002
6Cacodylic Acid (Cacodylate)IBA
06/2006 - 01/2002
5Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2008 - 03/2002
4DNA (Deoxyribonucleic Acid)IBA
11/2015 - 11/2004
4Thioacetamide (Thioacetamid)IBA
05/2008 - 01/2005
3Proteins (Proteins, Gene)IBA
03/2012 - 07/2009
3Phenobarbital (Luminal)FDA Link
01/2011 - 06/2006
31,4-dioxane (dioxane)IBA
11/2009 - 08/2008
32- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2007 - 07/2002
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2006 - 08/2003
3beta CateninIBA
01/2006 - 09/2005
2AsbestosIBA
05/2015 - 01/2013
2Carbon Nanotubes (Carbon Nanotube)IBA
05/2015 - 01/2013
2Ethyl Ether (Ether)IBA
01/2013 - 12/2004
29,10-Dimethyl-1,2-benzanthracene (DMBA)IBA
03/2012 - 07/2002
2Carrier Proteins (Binding Protein)IBA
03/2012 - 08/2003
2Epidermal Growth Factor (EGF)IBA
03/2012 - 11/2006
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2010 - 01/2010
2potassium bromateIBA
12/2009 - 03/2008
2Growth Factor ReceptorsIBA
11/2009 - 11/2006
2Bromodeoxyuridine (BrdU)IBA
05/2009 - 10/2005
2Ethanol (Ethyl Alcohol)IBA
03/2009 - 11/2005
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2008 - 01/2006
2Carbon Tetrachloride (Tetrachloromethane)IBA
10/2007 - 05/2002
2benzocycloheptapyridineIBA
01/2007 - 07/2002
2AzoxymethaneIBA
01/2007 - 07/2005
2Transforming Growth Factor alpha (TGF-alpha)IBA
06/2006 - 01/2004
2PlatinumIBA
01/2006 - 05/2003
2ParaffinIBA
01/2006 - 04/2004
2DDTIBA
11/2005 - 05/2002
2Cytochrome P-450 CYP2B1 (PROD)IBA
11/2005 - 08/2003
2Cisplatin (Platino)FDA LinkGeneric
10/2005 - 11/2002
2CollagenIBA
05/2005 - 01/2005
2Dimenhydrinate (DMH)FDA LinkGeneric
01/2005 - 12/2003
24- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamideIBA
01/2005 - 12/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2005 - 12/2003
2irinotecan (Camptosar)FDA LinkGeneric
12/2004 - 11/2002
2Methylnitronitrosoguanidine (MNNG)IBA
05/2004 - 10/2002
2Cyclin D1IBA
10/2002 - 08/2002
1Alkylating AgentsIBA
11/2015
1Dihydrotachysterol (AT 10)IBA
02/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015
1CytokinesIBA
10/2014
1Interleukin-2 (IL2)IBA
10/2014
1DiphenylamineIBA
07/2014
1AnnexinsIBA
03/2012
1Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2012
1Kininogens (Kininogen)IBA
03/2012
1ENNGIBA
03/2012
1Cysteine (L-Cysteine)FDA Link
03/2012
1CalciumIBA
03/2012
1Coloring Agents (Dyes)IBA
11/2010
1acivicin (AT 125)IBA
11/2010
1Serpentine Asbestos (Chrysotile)IBA
01/2010
1Pravastatin (Pravachol)FDA LinkGeneric
01/2010
1Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
01/2010
1Alkaline PhosphataseIBA
01/2010
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2009

Therapy/Procedure

4Oral Administration
01/2014 - 01/2006
2Ligation
12/2009 - 09/2009
2Gastrectomy
03/2008 - 09/2004